Latest IR information
IR News
- 2025.06.10
- Revision to Earnings Forecast for FY 2025
- 2025.06.10
- SymBio Announces Enrollment of the First Patient in International Phase Ib/II Clinical Trial of IV Brincidofovir for Malignant Lymphoma
- 2025.05.16
- 株主通信「SymBio VISION vol.27」(Japanese only)
- 2025.05.12
- SymBio Confirms Brincidofovir (BCV) Efficacy Against Malignant Brain Tumors and Identification of Biomarker Genes (Predictive Factors of Efficacy)
- 2025.05.08
- Summary of Consolidated Financial Statements for the First Three Months of Fiscal Year Ending December 31, 2025 [Japanese GAAP]